headerdesktop corintwktrgr26apr24

MAI SUNT 00:00:00:00

MAI SUNT

X

headermobile corintwktrgr26apr24

MAI SUNT 00:00:00:00

MAI SUNT

X

Promotii popup img

-50% -30% la Corint si Leda

siii TRANSPORT GRATUIT

la TOATE comenzile peste 50 lei!

Profita acum!

Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine

Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine - Alex Belser

Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine

Belser, Alex: - Alex Belser is a psychologist and psychedelic researcher in clinical trials at NYU and Yale University. He is also the co-co-founder of the psychedelic research group at NYU. He studied at Georgetown University, the University of Cambridge, Columbia University, NYU, and Yale University. He is the Chief Clinical Officer of Cybin, and served as Chief Clinical Officer at Adelia Therapeutics. Additionally, he is a member of Chacruna Institute's Women, Gender Diversity, and Sexual Minorities Working Group. He has investigated psilocybin and MDMA to treat depression, anxiety, substance use, OCD, PTSD, and end-of-life distress. He is co-author of EMBARK, a psychedelic-assisted psychotherapy model, and was a contributor to Psychedelic Justice: Toward a Diverse and Equitable Psychedelic Culture, (Synergetic Press, 2021).
Citeste mai mult

-10%

transport gratuit

PRP: 136.09 Lei

!

Acesta este Pretul Recomandat de Producator. Pretul de vanzare al produsului este afisat mai jos.

122.48Lei

122.48Lei

136.09 Lei

Primesti 122 puncte

Important icon msg

Primesti puncte de fidelitate dupa fiecare comanda! 100 puncte de fidelitate reprezinta 1 leu. Foloseste-le la viitoarele achizitii!

Livrare in 2-4 saptamani

Descrierea produsului

Belser, Alex: - Alex Belser is a psychologist and psychedelic researcher in clinical trials at NYU and Yale University. He is also the co-co-founder of the psychedelic research group at NYU. He studied at Georgetown University, the University of Cambridge, Columbia University, NYU, and Yale University. He is the Chief Clinical Officer of Cybin, and served as Chief Clinical Officer at Adelia Therapeutics. Additionally, he is a member of Chacruna Institute's Women, Gender Diversity, and Sexual Minorities Working Group. He has investigated psilocybin and MDMA to treat depression, anxiety, substance use, OCD, PTSD, and end-of-life distress. He is co-author of EMBARK, a psychedelic-assisted psychotherapy model, and was a contributor to Psychedelic Justice: Toward a Diverse and Equitable Psychedelic Culture, (Synergetic Press, 2021).
Citeste mai mult

De pe acelasi raft

Parerea ta e inspiratie pentru comunitatea Libris!

Acum se comanda

Noi suntem despre carti, si la fel este si

Newsletter-ul nostru.

Aboneaza-te la vestile literare si primesti un cupon de -10% pentru viitoarea ta comanda!

*Reducerea aplicata prin cupon nu se cumuleaza, ci se aplica reducerea cea mai mare.

Ma abonez image one
Ma abonez image one